Chemoinformaics analysis of Oxacyclohexadecan-2-one
Molecular Weight | 240.387 | nRot | 0 |
Heavy Atom Molecular Weight | 212.163 | nRig | 9 |
Exact Molecular Weight | 240.209 | nRing | 1 |
Solubility: LogS | -2.069 | nHRing | 1 |
Solubility: LogP | 2.105 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 45.3242 |
nHD | 0 | BPOL | 30.6938 |
QED | 0.558 |
Synth | 4.036 |
Natural Product Likeliness | 3.039 |
NR-PPAR-gamma | 0.017 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -4.373 |
MDCK | 0.0000259 |
BBB | 0.893 |
PPB | 0.615373 |
VDSS | 1.702 |
FU | 0.389271 |
CYP1A2-inh | 0.075 |
CYP1A2-sub | 0.718 |
CYP2c19-inh | 0.025 |
CYP2c19-sub | 0.917 |
CYP2c9-inh | 0.039 |
CYP2c9-sub | 0.102 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.455 |
CYP3a4-inh | 0.024 |
CYP3a4-sub | 0.377 |
CL | 14.569 |
T12 | 0.616 |
hERG | 0.012 |
Ames | 0.223 |
ROA | 0.559 |
SkinSen | 0.436 |
Carcinogencity | 0.115 |
EI | 0.821 |
Respiratory | 0.746 |
NR-Aromatase | 0.006 |
Antiviral | Yes |
Prediction | 0.79012 |